chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt rec'd vaccine's on 1/14/03, reported X 2 red hard knots to leg. 1/15/2003 advised to apply warm clothes  & warm water soak to leg . Went to ER on 1/16/03 due to redness from groin area to knee with hard knot to leg Tx with Benadryl and motrin.
Information has been received from a physician concerning a 21 year old female who on 11-JUL-2007 was vaccinated with a dose of GARDASIL. Concomitant therapy included MENACTRA and TETANUS ANTITOXIN USP (manufacturer unknown). On 11-JUL-2007, five minutes after vaccination the patient fainted. Medical attention was sought. The patient was recovered. No product quality complaint was involved. Additional information has been requested.
Hospitalized 10/10/2021; COVID-19 positive 10/09/2021; fully vaccinated  ED visit on 10/9/2021 discharged home:  Patient seen in conjunction with the physician assistant.  I agree with his assessment plan.  Patient is vaccinated against COVID-19 but now has symptoms that started 24 hours ago that are concerning for infection.  She is COVID positive here.  Vitals are within normal limits, no indication for hospitalization.  She does have a history of atrial fibrillation and heart disease with cardiomyopathy.  Does qualify for monoclonal antibody infusion.  I did review the treatment with her and cleaning risks and benefits.  Verbal consent was obtained.  Antibody infusion ordered.  Will be monitored post infusion for the appropriate amount of time HISTORY OF PRESENT ILLNESS: 87-year-old female who is currently vaccinated for COVID-19 presents emergency department with cough nasal congestion and rhinorrhea which started yesterday afternoon.  Patient states she otherwise feels fine and has not had any fevers chills sweats chest pain chest pressure shortness of breath and is not coughing anything up.  Patient states she took Tylenol yesterday states she currently has no pain is 0/10 on the pain scale.  Patient states she also received her flu shot yesterday.  Patient denies any muscle aches and nausea vomiting diarrhea.  Patient states that on Wednesday she saw her grandson who had some mild upper respiratory symptoms and they just got him tested and he is currently positive for COVID-19. Assessment/Plan    DIAGNOSIS at time of disposition: 1. COVID-19 virus infection  2. Encounter for laboratory testing for COVID-19 virus     Discharge summary  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia COVID-19    HOSPITAL COURSE: 87 y/o female with history of atrial fib on xarelto, chronic HFpEF, hyperthyroid, Crohn's.  Positive COVID and received monoclonal antibody infusion on 10/09.  Returns with worsening shortness of breath, orthopnea.  She is fully vaccinated since March 2021.  Initially on 6L NC, and then requiring high flow and weaned back down to NC after lasix. She was diagnosed with a combination of heart failure and COVID-19 and admitted to the hospitalist service. She was started on decadron and remdesivir for COVID-19. Her oxygen was weaned to room air. Ambulatory pulse ox was stable and did not drop below 92%. Her stay was uncomplicated. She got her dose of remdesivir prior to discharge. She will finish her course of decadron outpatient. She was discharged home in stable and improved condition.      Active Issues Requiring Follow-up Issue: covid PNA Recommended follow-up provider/specialty: PCP What is needed: close outpatient follow up, continue follow up with GI   DISCHARGE DISPOSITION: Home without services
This spontaneous report was received from a register nurse refers to a 13 years old patient, who on an unknown date, was vaccinated with PROQUAD (dose, route and lot not reported). No adverse effect was reported. No concomitant medications were reported. Additional information has been requested.
Weakness and muscle pain in arm for 2 weeks so far,  pain level 7, interrupted sleep, neck and upper back pain, tingling sensation in hand.
Patient received shot on Monday (12/18) and came to pharmacy on 12/23 to ask about intense bruising on arm where vaccine was administered. Bruising was below injection site and patient stated Thursday was when the bruising looked the worst. It had improved since Thursday. Patient stated it was not painful, unless touched. Her concern was if she was having an allergic reaction to the actual vaccine.
at 11:30 am the day after vaccine i began to feel chills, shaking, and they after eating something i started feeling nausea, headache and fever.   Drove home at  2:30 to 3:30 and checked my fever, it was 104.    Injection site is swollen, tender, red, and was not like that the day of injection.
Needle hub detached from the syringe, pt received at least 50% of vaccine, no additional vaccine given
Severe Dizzy, Nausea, vomited x5, elevated HR and Elevated BP .  No short of breath, no fever. Day 4 still dizzy, nausea but vitals stable
10/12/15 flu vaccine giving lightheaded after injection and queasy. Rash on her arm. Diffuse itchiness to her chest and neck. 10/16/15> seen in employee health, injection site red 20 mm and itching. BENADRYL, 10/21/15 > seen by dr; continues BENADRYL so needed; avoid flu vaccine.
mom reported site pain-tender to touch w/swelling; pain persisted w/swelling radiating to the ant of the arm w/lymph node swelling lasted approx 7 days; arm swelling & pain & tenderness; resolved lt lymph node remains swollen
It was reported that a male in his 50's received Fluzone SV 98-99 USP on 10/23/98. Reportedly later that day the pt complained of sleeplessness. From additional information received on 11/20/98 it was reported that he was unable to fall asleep until 2:00 am. Felt like he had too much energy. Reportedly the pt recovered from this experience.
I developed rash on arm near injection site. It's very red and itchy. I have been putting hydrocortisone cream on for the itching. And I have had to take Hydroxyzine if the itching was severe. I also have an autoimmune disorder.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent condition, or concomitant medication. On or about 11-NOV-2013, the patient was vaccinated with ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of atypical herpes zoster. On or about 27-FEB-2016, the patient was treated by a physician for painful vesicular outbreak accompanied by symptoms of weakened immunity, which was diagnosed as severe herpes zoster, or shingles. The patient has been prescribed acyclovir and "Loritib" for management of her painful condition. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and require extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Information has been received from a person working in a physician's office concerning a patient with gastroesophageal reflux disease, who on 12-OCT-2007 received an oral dose of RotaTeq vaccine and within hours developed diarrhea. As of this report, the diarrhea had not resolved. A product quality complaint was not reported. No Further information was available. Additional information has been requested.
received the first dose of the Pfizer COVID-19 vaccine on 29JAN2021. Yesterday he tested positive for COVID-19; received the first dose of the Pfizer COVID-19 vaccine on 29JAN2021. Yesterday he tested positive for COVID-19; This is a spontaneous report from a contactable consumer (Patient). A 51-year-old male patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection), via an unspecified route of administration on 29Jan2021 at single dose for Covid-19 immunisation. The patient Medical history and concomitant medications were not reported. It was reported that Patient tested positive for covid-19 after the vaccination On 17Feb2021. The patient underwent lab test and procedures which included sars-cov-2 antibody test: which resulted positive on 17Feb2021. The outcome for the event was unknown.  Information about lot/batch number has been requested.
The 1st Moderna COVID-19 vaccination dose was administered on August 27, 2021, to discover after the injection was given the vaccine had expired on August 20, 2021.  The vaccine remained in the freezer until 30 minutes before usage when my supervisor pulled the vaccine out and inspected the bottle, I then in turn inspected the bottle before administration only seeing the lot number and not double checking for the expiration date.  The vaccine freezer and refrigerator temperatures are monitored daily on the weekdays, and have not been out of the suggested temperature range.    The vaccine bottle was not tampered with and did not look to be contaminated, or discolored.  The patient has not reported any adverse reactions or side effects other than a sore arm.
This spontaneous report was received from an 83-year-old male patient. The patient's medical history included varicella. No information regarding the patient's concurrent conditions, concomitant medications, drug reactions or allergies was provided. On an unknown date in the past, the patient was vaccinated with ZOSTAVAX (dose, frequency, route of administration, lot# and expiration date were not reported). On an unknown date, the patient stated that he did remember having an unspecified shingles outbreak. The outcome of shingles was reported as recovered. The relatedness between the event and ZOSTAVAX was unknown.
Both temples were piercing, headache, entire jaw; Both temples were piercing, headache, entire jaw; Blood pressure 260/180, 230/150; Little achy; This spontaneous case was received on 03-Nov-2021 from other non-health professional (consumer) via Agency (reference number: SEQW21-05032) and concerned a 71-year old female patient. The patient medical history included borderline hyperlipidemia, arthritis, systemic mastocytosis and diabetes. The patient concomitant medications were not provided. The patient's historical vaccines included all three Moderna vaccines (Covid-19 vaccine). The patient waited four weeks after the last booster.   On 28-Oct-2021, the patient was vaccinated with influenza virus vaccine polyvalent (brand not specified; dose, route of administration and anatomical location: not reported) as prevention of seasonal influenza. The batch number was not reported. The patient was not aware which of the Seqirus vaccines she had been administered, but it was one of the quadrivalents.   On 29-Oct-2021 and 30-Oct-2021, after receiving influenza virus vaccine polyvalent, the patient was little achy.   On 30-Oct-2021, the patient recovered from 'ache'.   On 31-Oct-2021, in the morning, the patient's blood pressure was 136/72. Later, the patient's both temples were piercing and entire jaw. The patient experienced headache and blood pressure in the afternoon was 260/180. The patient went to emergency room and was hospitalised. The blood pressure while presenting to the emergency room was 230/150. The patient was on a drip to get blood pressure down over night. While hospitalized, the patient was given Hydralazine (hydralazine hydrochloride) as treatment, and computed tomography (CT) scan was performed, but results were not reported.  On 02-Nov-2021, the patient was discharged from the hospital.  At the time of initial reporting, the patient was recovering from the events of hypertension and headache, reported as subsided.   The outcome of 'jaw pain' was not reported.   The patient did not provide causality assessment. The patient was not sure if the events were related to Moderna Covid-19 vaccine or influenza virus vaccine.    The events of 'hypertension', 'headache' and 'jaw pain' were considered as serious due to hospitalisation.  Company comment: A 71-year-old patient experienced hypertension, jaw pain, headache, and ache within three days after receiving influenza virus vaccine polyvalent. The patient concomitant drugs were not provided. Although advance age of patient, systemic mastocytosis and diabetes contributed to the development of the events, causality is assessed as possibly related, due to compatible time relationship.; Sender's Comments: A 71-year-old patient experienced hypertension, jaw pain, headache, and ache within three days after receiving influenza virus vaccine polyvalent. The patient concomitant drugs were not provided. Although advance age of patient, systemic mastocytosis and diabetes contributed to the development of the events, causality is assessed as possibly related, due to compatible time relationship.
Severe swelling of right kidney.  In the course if diagnosing this problem, they discovered a 2.6X2.5 cm mass on left ovary which will require further follow up.
hands & feet were like ice blocks every joint in my body ached 102 temperature till fever broke in bed for 20 plus hours did not leave my home I have not felt this ill for over 10 years
Patient experienced flu-like symptoms, cold and hot flashes, next day after Td injection. One week after Td injection patient could not extend her wrist and experienced weakness and numbness in her fingers. Patient was diagnosed with paralysis to the radial nerve.  Follow-up 12/15/06 location of radial nerve paralysis is on the right arm, same as vaccination site.
PERICARDITIS; MYOCARDITIS; This spontaneous report received from a patient via a company representative 161 patients of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch numbers: unknown, Expiry: unknown) dose, start therapy date were not reported 1 total for prophylactic vaccination. The batch numbers were not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patients experienced pericarditis, and myocarditis. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pericarditis and myocarditis was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0- 20211035322- covid-19 vaccine ad26.cov2.s Myocarditis, Pericarditis. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
patient presented to emergency department on 1/9/22 with weakness and nausea and vomiting patient was admitted for further management of nausea patien was found to be covid 19 jpositive on 1/9/22 patient did not require treatment for symptoms associated with covid 19 infection patient was discharged to home on 1/12/22
I had been having these health issues since January 2020 but believe I was being misdiagnosed with panic attacks by my GP and not certain this was from the COVID vaccines. On May 20, 2021 around 10pm my heart rhythm got out of sync and it felt like my heart was flipping. I had my husband take me to the ER at 3am (May 21, 2021). The ER had to sedate and shock my heart to get a normal heartbeat. I was ultimately asked if I had had COVID and diagnosed with POTS. Our family believes we had COVID in January 2020 but no testing was available to know for sure.
Presented 07/03/15 2115, c/o LUE redness and induration, throbbing pain 8/10 with onset 07/01/2015. Administered Keflex and Bactrim 07/03/15 @ 2145 and released to housing unit. 07/04/15 reassessement with significant decrease in erythema and induration on LUE.
Patient brought to clinic on 4/6/06 to have PPD read.  Mother stated that son's Left upper arm had been red, swollen and hot to the touch since vaccines were adm. on 4/3/06.  MD examined arm and told mother to administer Benadryl as needed to relieve swelling and Tylenol as needed for pain.
Next day bad headache, two days later bad GI upset, stomach pain inflammation ; 2nd vaccine Psfizer
Extremely painful back of head, neck pain.. Painful to put head on the pillow. Unlike my usual neck arthritis. Did not connect it at first to the vaccine. First week was the most painful, second week better.
headache, Flushed, CP 2/1, PMH (PDA) Tx: none - 35 min observation no adverse reactions noted by 15:51 Allergy review recommended 2nd injection 1/16/21 - 30 min observation follow up no signs/symptoms adverse reaction
This spontaneous report received from a patient via a company representative concerned a patient of unspecified age, sex race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: mild headache. The patient was previously received covid-19 vaccine (dose number in series 1) (suspension for injection, route of admin, and batch number were not reported) does not reported,1 in total administrated on MAR-2021 for prophylactic vaccination. On an unspecified date, following vaccination the patient had negative side effects for less than 24 hours (dose number in series 1), but felt great after that. It was reported that after receiving the first dose of vaccine the fatigue, joint pain, mild headache went away (unexpected therapeutic benefit) (dose number in series 1). On an unspecified date, a month ago the patient had fatigue and joint pain again. The patient received covid-19 vaccine (dose number in series 2) (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported, 1 total administrated for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, after booster dose all pain went away (unexpected therapeutic benefit) (dose number in series 2). The action taken with covid-19 vaccine was not applicable. The outcome of unexpected therapeutic benefit was not reported. This report was non-serious. This case, involving the same patient is linked to 20211226110.
The participant did not have symptoms right away but she is diagnosed with the diabetes and still is sick. She had to take off work for a couple of days. She went to the ER and had tests done and checks up with the doctor regularly. When i went to the ER i was in the worst condition for two hours.  The second vaccine made her body weak, according to the patient she thinks all of the medical conditions she has been experiencing is because of the vaccination. I had a lot of trouble sitting and working for a long period of time because my blood pressure kept shooting had to go the doctors a couple of time.
A healthcare professional reported that a 61 year old female received an injection of Flu Shield '00-'01 on 12/06/00. Within 24 hours, the pt developed a rash with hives on her forearms, neck, and trunk, pruritus and wheezing. The pt was treated with epinephrine and Benadryl but the rash worsened. The reporter noted that Flovent therapy "may also be the cause" of the events.
Pt received flu vaccine on 12/14/2001. Now with erythema and blistering 1.5 cm by 1.5 cm at injection site.
pt recv vax 8APR99 & w/in 5min post vax pt became cyanotic & bradycardic;MD office was unable to obtain pulse oximetry & HR was approx 88 bpm;color sl improved on 02 via mask;pt taken to hosp tx in ER;pt released 8hr later;
Blurred vision, dilated pupils, right facial droop, nuscle weakness in face, told i have mold bells palsy.
first lesion appeared on 07/04/02 on face then spaputic lesions on front, legs, buttocks, scrotum.
1 1/2 in. x 1 1/2 in. red raised area at Varicella site. Treated with Keflex.
No aditional adverse events reported; improperly stored vaccines may have been administered to patients; This spontaneous report has been received from a nurse, referring to a patient of unknown gender and age. Information about the patient's pertinent medical history, concurrent conditions, and previous drugs reactions or allergies were not provided.  On 18-DEC-2019, the patient was vaccinated with an improperly stored (product storage error), pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (Therapy type: Digital Data Logger), lot number S003872 and expiration date 22-DEC-2020 for prophylaxis (strength, dose, dose number, frequency, route of administration, and anatomical location, were not provided).  The vaccine was stored at a temperature above 47 degree Fahrenheit (47.1 Fahrenheit), for a timeframe of 8 to 16 minutes, with no previous temperature excursion. The call was due to a Digital Data Logger.  No additional adverse events were reported.  This case is one of several cases from the same reporter.; Sender's Comments:  US-009507513-2001USA009007:
Patient had pain for approximately 24 hours, changing to inflammation, hives and rash on right arm.
Hives and itchiness on stomach and lower back. Hives on the inside of the thighs, but not itchy.; itchiness on stomach and lower back.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 09Apr2021 at 17:00 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On an unknown date in Apr2021, the patient experienced hives and itchiness on stomach and lower back and hives on the inside of the thighs, but not itchy. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of events which included treatment with Benadryl. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events hives and itchiness on stomach and lower back and hives on the inside of the thighs, but not itchy were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Pt recd 1st dose of Hep B vax 17MAY89 & later devel swelling & soreness @ inject site; explosive, voluminous, clear mucoid lumpy, bloody bowel discharge w/no apparent stool. No assoc. gastroenteritis, pt felt "weird".
Patient came in too soon for their second shot. Only 2 weeks instead of 3 weeks
One day after injection i had red itchy burning rash at injection site. Took 2 days to subside.
Next day p/vax recvd pt had t104 APAP given then t100 4 hrs later; t104 taken to hosp; lasted 5 days;
Sub occipital lymph nodes-one; large one on the left, 2 smaller ones on right.
The next day after the shot when I woke up I started peeing blood and I now have a body rash